Results 101 to 110 of about 113,459,886 (161)

Comparative assessment of the effects of dotinurad and febuxostat on the renal function in chronic kidney disease patients with hyperuricemia

open access: yesScientific Reports
Although hyperuricemia is associated with chronic kidney disease (CKD), the impact of uric acid (UA)-lowering drugs on CKD has been controversial.
Tomoaki Takata   +8 more
doaj   +1 more source

Structural basis for urate recognition and apigenin inhibition of human GLUT9

open access: yes
Urate, the physiological form of uric acid and a potent antioxidant in serum, plays a pivotal role in scavenging reactive oxygen species. Yet excessive accumulation of urate, known as hyperuricemia, is the primary risk factor for the development of gout.
Xiaofei Ge   +8 more
core   +1 more source

Real-world use of dotinurad and one-year prescription presence by kidney function in older adults

open access: yesScientific Reports
Evidence on dotinurad, a selective urate transporter 1 inhibitor, in older adults with reduced kidney function is limited. We conducted a retrospective cohort study using the Japan Medical Data Center elderly claims database from April 2021 to February ...
Ryosuke Saiki   +6 more
doaj   +1 more source

Urate transport capacity of glucose transporter 9 and urate transporter 1 in cartilage chondrocytes. [PDF]

open access: yesMol Med Rep, 2019
Zhang B   +10 more
europepmc   +1 more source

Characterization of Urate Transport System in JAR and JEG-3 Cells, Human Trophoblast-derived Cell Lines [PDF]

open access: yes
Urate (uric acid) is the major inert end product of purine metabolism in humans. Since it is water soluble, it requires a membranous protein called transporter for its permeation across the plasma membrane.
Ouchi, Motoshi   +8 more
core   +1 more source

Extra-renal role of urate transporter-1 in diabetes. [PDF]

open access: yesWorld J Diabetes
Yang TS, Du M, Luo LY, Lin L, Luo XL.
europepmc   +1 more source

The Human Urate Transportosome: Evolutionary Dynamics, Molecular Mechanisms, and Pharmacogenetic Perspectives. [PDF]

open access: yesMed Sci (Basel)
Dzhemileva LU   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy